# Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

> **NCT03198728** · PHASE3 · COMPLETED · sponsor: **Marius Pharmaceuticals** · enrollment: 314 (actual)

## Conditions studied

- Hypogonadism, Male

## Interventions

- **DRUG:** SOV2012-F1
- **DRUG:** AndroGel

## Key facts

- **NCT ID:** NCT03198728
- **Lead sponsor:** Marius Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-05
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198728, "Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03198728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*